Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.

about

Epidemiology and reporting of candidaemia in Belgium: a multi-centre study.

P2860

Q36196229-8B4A8489-B100-4CD3-9B88-E5F99B578A0B

P2860

Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.

Item

http://www.wikidata.org/entity/Q40168402

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Echinocandin to fluconazole st ...... e Candida albicans infections.

@en

type

Item

label

Echinocandin to fluconazole st ...... e Candida albicans infections.

@en

prefLabel

Echinocandin to fluconazole st ...... e Candida albicans infections.

@en

P1476

Echinocandin to fluconazole st ...... e Candida albicans infections.

@en

P2093

A B Johan Groeneveld

http://www.w3.org/2001/XMLSchema#string

Alieke G Vonk

http://www.w3.org/2001/XMLSchema#string

Patrick J van der Geest

http://www.w3.org/2001/XMLSchema#string

P2860

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

Breakthrough invasive candidiasis in patients on micafungin.

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome.

Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

Treatment of candidemia with echinocandins: data on hospital resource use from a real world setting.

Anidulafungin versus fluconazole for invasive candidiasis.

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.

Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality.

Diagnosis of invasive candidiasis in the ICU.

P304

179-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/MYC.12450

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bart Rijnders

P577

2015-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26707572

http://www.w3.org/2001/XMLSchema#string

Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.

about

P2860

P2860

Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698